Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 8/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.51 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.50 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.48 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.45 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.45 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1086081 | 1.00 | LPAR5 (0.65) | LPAR5USP2HTTS1PR1CYP1A2 | |
| SCHEMBL1086055 | 0.84 | LPAR5 (0.57) | LPAR5USP2HTTS1PR1CYP1A2 | |
| SCHEMBL1086057 | 0.84 | LPAR5 (0.57) | LPAR5USP2HTTS1PR1CYP1A2 | |
| SCHEMBL1086073 | 0.84 | LPAR5 (0.57) | LPAR5USP2HTTS1PR1CYP1A2 | |
| SCHEMBL11005207 | 0.83 | LPAR3 (0.66) | LPAR5S1PR1LPAR3LPAR1S1PR2 | |
| SCHEMBL8933348 | 0.83 | LPAR1 (0.59) | LPAR5S1PR1LPAR3LPAR1S1PR2 | |
| SCHEMBL2059626 | 0.83 | LPAR1 (0.59) | LPAR5S1PR1LPAR3LPAR1S1PR2 | |
| SCHEMBL19257794 | 0.82 | USP2 (0.74) | LPAR5USP2HTTCYP1A2CYP3A4 | |
| SCHEMBL4523337 | 0.81 | LPAR5 (0.66) | LPAR5USP2HTTCYP1A2CYP3A4 | |
| SCHEMBL31145925 | 0.81 | LPAR5 (0.60) | LPAR5USP2HTTLPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153615-B2 | Synthesis of glycerolipid carbamates and dicarbamates and their use as an antitumor compounds | THE UNIVERSITY OF MANITOBA (CA) | 2012-04-10 | — | — | US | disclosed |
| US-20090042811-A1 | Synthesis of Glycerolipid Carbamates and Dicarbamates and Their Use as an Antitumor Compounds | THE UNIVERSITY OF MANITOBA (CA) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042811-A1 | Synthesis of Glycerolipid Carbamates and Dicarbamates and Their Use as an Antitumor Compounds | PHOSPHO1, SGMS1, UGCG | LPAR5 708/4885USP2 1122/4885HTT 4036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.